A statement... per the PR on CytoDyn website. Noti
Post# of 148151
"The note, has a two-year maturity, bears interest at the rate of 10% per annum and is secured by all assets of the Company, excluding its intellectual property. The note may be converted at the option of the investor into shares of the Company’s common stock at a conversion price of $10.00 per share."
https://www.cytodyn.com/newsroom/press-releas...onvertible